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Abstract 
Introduction: There are four types of 
Chiari malformations described in the 
literature. Due to the fact that it is a 
common finding in the general population 
(true Chiari being present in 0,75% of the 
population), Chiari 1 malformation was 
also called Chiari anomaly. 
Material and methods:      In the last 5 years 
17 patients with Chiari I malformation have 
been treated in our clinic. There were 12 
women and 5 men. The mean age was 43 
years  (between 21 and 60 years). The 
symptoms were grouped in 6 syndromes: 
brain stem and bulbar palsy syndrome, 
cerebellar syndrome, central cord 
syndrome, paroxysmal intracranial 
hypertension, scoliosis, pyramidal 
syndrome. 
Surgical treatment: According to recent 
literature patients respond best when 
operated within 2 years from the onset of 
symptoms. We recommend early surgery 
for symptomatic patients. Surgical 
treatment of Chiari I malformation should 
accomplish several golds. First of all, there 
is the obvious need to decompress the 
lower part of the cerebellum. Chiari I 
malformation being related to a small 
posterior fossa, the surgical treatment 
should realise enlargement of the total 
volume of the posterior fossa(7, 12). In the 
author’s opinion the key point in surgical 
treatment of Chiari 1 malformation should 
be to reestablish the CSF flow at the level 
of the foramen of Magendie and foramen 
magnum. Various approaches were used in 
the last five years in our clinic for the 
treatment of symptomatic patients:  only 
osseous decompression in 2 patients; osseus 
decompression with dural grafting and 
intradural dissection of adhesions in 4 
patients; osseous decompression with dural 
grafting, intradural dissection, and tonsillar 
coagulation in 11 patients 
Results: The long-term (6 months 
postoperative) surgery-related result was 
considered excellent if symptoms resolved 
(7 patients). The result was considered 
good if the patient experienced significant 
improvement but also residual symptoms 
(8 patients). A poor result indicated no 
change in symptoms  (2 patients). As for the 
surgical technique used, the vast majority of 
patients with good or excellent outcome at 
6 months underwent  osseous 
decompression with dural grafting, 
intradural dissection, and tonsillar 
coagulation 
Conclusions: Regarding Chiari I 
malformations, the author considers that a 
proper patient selection is critical to prevent 
unnecessary procedures and maximize the 
outcome. In light of this study results and 
recent literature, the author considers that 
the surgical gold standard consists in three 
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key steps:  posterior fossa craniectomy 
followed by durotomy and subarachnoid 
decompression of CSF flow and last 
duroplasty. 
Key words: small posterior fossa, osseous 
decompression, dural graft, syringomyelia 
Introduction 
Chiari malformations are perhaps one of 
the most controversial topics in 
neurosurgery today. There is a lack of 
agreement as to what defines these 
malformations, their symptoms and their 
natural history. If treatment is necessary, a 
wide variety of techniques have been 
proposed (9, 12). There are four types of 
Chiari malformations described in the 
literature. Due to the fact that it is a 
common finding in the general population 
(true Chiari being present in 0.75% of the 
population), Chiari 1 malformation was 
also called Chiari anomaly while Chiari 2 
malformation is usually associated with 
myelomeningocele and is found only in this 
population (23, 29). Chiari 3 and 4 
malformations are extremely rare 
pathologies and are usually fatal until the 
age of two. 
Epidemiology 
In a large series of patients, the mean age 
of onset of Chiari I malformation is 
reported to be 25 years, and women 
account for 75% of patients.  Average 
duration of symptoms clearly related to 
Chiari  I is 3.1 years (range 1 month – 20 
years)(9). 
Material and methods 
In the last 5 years 17 patients with Chiari 
I malformation have been treated in our 
clinic. There were 12 women and 5 men. 
The mean age was 43 years  (between 21 
and 60 years). 
The symptoms were grouped in 6 
syndromes: 
1. Brain stem and bulbar palsy 
syndrome: caused by brainstem 
compression or syringobulbia ,including 
variable involvement of the cranial nerves, 
lower brain stem. 
Symptoms include “down-beating” 
nystagmus (1 patient), sleep apnea (2 
patients),  vocal cord dismotility (2 
patients),  extraoccular eye movement 
abnormality (2 patients), hearing loss (2 
patients), tinnitus (2 patients),  dysphagia (5 
patients) , headache (9 patients), neck pain 
(6 patients). 
2. Cerebellar syndrome:  
Ataxia of the limbs or trunk (3 patients), 
nystagmus (2 patients), dizziness (6 
patients) and dysarthria (3 patients) 
3. Central cord syndrome:  caused by 
canal compression or syringomyelia, 
including pain (frequently “ burning” )  (7 
patients), dissociated and posterior column 
sensory loss (12 patients). 
4. Paroxysmal intracranial hypertension:  
exertional headache and nausea, vomiting, 
and dizziness associated with a headache 
episode (in  2 patients) 
5. Pyramidal syndrome: stiffness and/or 
spasticity and hyperreflexia (10 patients), 
motor weakness and variable long tract 
signs (8 patients), atrophy (3 patients). 
6. Scoliosis (3 patients). 
Mri evaluation 
Magnetic resonance imaging of the 
cranio-spinal junction represents the gold 
standard diagnostic tool.  A descend of 
tonsils of 5 mm or more below the foramen 
magnum is considered a pathological 
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tonsilar ectopia (18, 20), but this is still 
under debate (figure 1). 
 In our study we classified the tonsils 
ectopia into two major groups: tonsils 
descended to C-1 (12 patients) and tonsils 
descended to C-2 or lower (5 patients). We 
also realised head CT scans which revealed 
osseous anomalies such as small posterior 
fossa in 3 patients and platybasia in one 
patient. We have also stoduied the presence 
of syrinx associated with Chiari type 1 
malformation (figure 2). 
 
  
A                                B 
Figure  1 A: Sagittal T1-weighted MR image of the 
brain showing herniation of cerebellar tonsils and a 
low-lying obex characteristic of Chiari malformation 
Type I. B: Sagittal MR images of the 
cervicothoracicspine revealing syringomyelia 
 
 
Figure 2 T2-weighted MR images of the spinal cord 
showing  a holocord syrinx 
 
 
Indications for surgery 
According to recent literature patients 
respond best when operated within 2 years 
from the onset of symptoms. We 
recommend early surgery for symptomatic 
patients. Asymptomatic patients may be 
followed and operated upon if and when 
they become symptomatic (6, 8, 13).  
For patients who have been symptomatic 
and stable for years, we consider that 
observation is the correct management, 
surgery being indicated only if signs of 
deterioration appear. 
There are several strong indications for 
posterior fossa decompression such as drop 
attacks, dysphagia with aspiration, apnea 
and the presence of syrinx (1, 2). 
 Headache represents a controversial 
indication for surgery when it is the only 
symptom. We recommend using imagistic 
studies such as Cine MRI  to establish CSF 
flow impairment at the foramen magnum. 
If positive, surgery should be considered 
(4).  
Objectives of surgery 
In the author’s opinion, surgical 
treatment of Chiari I malformation should 
accomplish several golds. First of all, there 
is the obvious need to decompress the 
lower part of the cerebellum. Chiari I 
malformation being related to a small 
posterior fossa, the surgical treatment 
should realise enlargement of the total 
volume of the posterior fossa (7, 12).   
In the author’s opinion the key point in 
surgery treatment of Chiari 1 malformation 
should be to reestablish the CSF flow at the 
level of the foramen of Magendie and 
foramen magnum.  
Although numerous techniques of 
surgery have been proposed since Chiari 
first described the patology, all of them 
have been reported with advantages and 
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disadvantages, and none of them managed 
to fully accomplish the desired golds of 
surgery. 
Techniques of surgery 
Various approaches have been used for 
the treatment of symptomatic patients in 
our clinic in the last five years:  only 
osseous decompression in 2 patients; osseus 
decompression with dural grafting and 
intradural dissection of adhesions in 4 
patients; osseous decompression with dural 
grafting, intradural dissection, and tonsillar 
coagulation in 11 patients. We perform a 
more aggressive decompression and 
intradural dissection when a syrinx is 
present.  
 I. Osseus  decompression (cranio-vertebral 
decompression/ laminectomy) 
First of all, the craniectomy should not 
be larger than 3x3 cm in order to avoid 
cerebellar sag (11, 16, 24). The author 
recommends C1 laminectomy in most 
cases, but extension to C2 laminectomy is 
also possible this being directly related to 
caudal displacement of the cerebellar tonsils 
(figure 3). 
 
 
Figure 3 Suboccipital craniectomy and C1 
laminectomy 
II. Opening of the dura + intra-arachnoid 
dissection 
Opening of the dura and intraarachnoid 
dissection of the scarring are, in the 
author’s opinion, the essential steps in 
Chiari I surgery. The author strongly 
recommends them because osseus 
decompression only, does not achieve one 
of the main objectives of surgery,  
increasing the global volume of the 
posterior fossa. The dura is opened through 
a Y shaped incision (figure 4 A). The next 
step is represented by intraarachnoid 
dissection of the arachnoid scarring, 
reestablishing the normal CSF flow. 
 Visualization of the choroid plexus of 
the 4th  ventricle and free flow of CSF into 
the subarachnoid space consist in our 
opinion the proof of adequate 
decompression (figure 4 B). The author 
prefers not to aggressively resect the 
herniated tonsils; instead he realises a 
controlled and  intended tonsillar ischaemia 
with bipolar coagulation of PICA tonsillar 
branches. The author also tries to maintain 
the flow of the CSF through the foramen of 
Magendie, by  lateral  suspension of the 
medial part of the tonsills (figure 4 C). 
 The author prefers to reserve 
syringomyelic drainage for patients who fail 
to respond (clinically, not radiologically) to 
initial posterior fossa decompression. 
Avoiding the risks and complications 
associated with shunting procedures is 
desirable. 
 
 
A 
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C 
Figure 4 A   Y shaped durotomy; B Internal 
debulking and coagulation of tonsils; C Lateral  
suspension of the medial part of the tonsils 
 
III. Dural graft  
Dura mater being inextensible, the 
author considers that in order to achieve 
one of the goals of treatment (enlargement 
of the posterior fossa), it needs to realise a 
dural graft. The author uses autologous 
graft – pericranium – in order to achieve a 
tight closure of the dura without CSF leak 
(figure 5). 
Tight closure of the dura is mandatory 
in our opinion because it prevents blood 
leakage from the extradural to the intradural 
space thus preventing subdural/intra-
arachnoid scarring. Also, it prevents CSF 
leakage and pseudomeningocele (30, 33). 
Typical postoperative care involved the 
patient staying overnight in an intensive 
care unit. Patients were discharged from the 
hospital between 4 and 10 days 
postoperatively. 
 
 
 
 
 
Figure 5 Duroplasty with pericranium 
Results 
Postoperatively, the condition of the 
patients was reassessed at the follow-up 
visits (1 month, 3 months, 6 months, 1 
year) according to: symptoms resolution; 
signs and symptoms improvement;  no 
change;  signs and symptoms worsening. 
Those associated with poor outcome 
include, signs or symptoms suggestive of 
syringohydromyelia; atrophy suggest a 
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similarly poor prognosis, whereas weakness 
in the presence of atrophy is bad response 
to surgery, as might be expected with the 
loss of alpha motor neurons.  Sensory loss 
has been widely recognized as largely 
unresponsive to surgery (figure 6). 
Headache specifically, sleep apnea, and  
cervical pain in general appear to respond 
best. Weakness in the absence of atrophy 
tends to respond well, while mild scoliosis, 
seems to respond reasonably well to surgery 
(figure 7). 
       Patients with signs of cerebellar 
syndrome and paroxysmal intracranial 
hypertension respond best to surgical 
management, followed by patients with 
pyramidal and brain stem syndromes. 
Postoperative MR imaging assessment of 
the operative site in all patients 
demonstrates that the level of cerebellar 
tonsils was normal, the cisternal space at the 
level of the foramen magnum was indeed 
enlarged, and the width of CSF column 
around the spinal cord was enlarged. 
Postoperative spinal MR images obtained to 
assess the syringomyelia revealed the 
disappearance of the syrinx in 5 cases, and a 
significant decrease in syrinx size in 7 
patients (figure 8). 
The long-term (6 months postoperative) 
surgery-related result was considered 
excellent if symptoms resolved (7 patients).  
 
 
Figure 6 Poor outcome symptoms and signs 
 
 
Figure 7 Good outcome signs and symptoms 
 
 
 
Figure 8 Preoperative/postoperative MRI showing 
the reduction of syrinx 
 
The result was considered good if the 
patient experienced significant 
improvement but also residual symptoms 
(8 patients). A poor result indicated no 
change in symptoms  (2 patients). 
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As for the surgery technique used, the 
vast majority of patients with good or 
excellent outcome at 6 months underwent  
osseous decompression with dural grafting, 
intradural dissection, and tonsillar 
coagulation (Figure 9). 
 
Figure 9 Long-term outcome in relation to the surgery technique used 
 
Complications 
There are several types of complications. 
We distinguish between complications 
related to conservative surgery (inadequate 
surgery) and actual postoperative 
complications (9, 11). 
 In our study the complications were 
mostly postoperative complications and 
included CSF leakage (1 patient), aseptic  
meningitis (2 patients), intraoperative 
changes in cardiovascular parameters (1 
patient), and pseudomeningocele (1 
patient).  
Postsurgical moderate headaches, neck 
pain and fever represent the so-called 
"aseptic" meningitis and were regarded as 
adverse events rather than outright 
complications. Analysis of a CSF sample 
did not reveal evidence of infection and 
were successfully treated with steroid and 
analgesic medications. The symptoms 
resolved within a postoperative period no 
longer than 3 weeks and had no influence 
on the final treatment result. 
The CSF leak required  wound revision 
and lumbar drainage. 
At later follow up, a pseudomeningocele 
was  clinically and radiologically 
demonstrated in one patient. No treatment 
was required.  
We had one recurrence due to 
conservative surgery (incomplete 
decompression). In this case only an 
extradural decompression was realised, so 
we performed dural grafting, intradural 
dissection, and tonsillar manipulation and 
coagulation on the second surgery. 
Discussion 
In our clinic’s series, surgical treatment 
of Chiari I malformation consisted of 
suboccipital craniectomy only (2 cases), 
arachnoid dissection of scarring (4 patients), 
reestablishing the CSF flow at the foramen 
of Magendie by shrinkage of the tonsils and 
duraplasty with autologous material 
(pericranium) (11 patients).  
The most important question that 
remains to be answered is whether good 
results could be achieved by leaving the 
arachnoid or dura intact. According to some 
authors, leaving the dura and the arachnoid 
intact can result in lower complication 
rates, but this data is counterbalanced by 
high rates of recurrence of symptoms and 
the need for revision surgeries. Also, leaving 
the dura and the arachnoid intact results in 
0
1
2
3
4
5
6
7
Simple osseus 
decompression
Osseus decompresion 
+intraarachnoid 
dissection +dural graft
Osseus decompresion 
+intraarachnoid 
dissection and tonsilar 
coagulation+dural graft
Poor outcome
Good outcome
Excelent outcome
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lower rates of syrinx reduction (7, 14, 22). 
The outcome data resulted from McGirt 
et al study (21)  (which used a simple 
decompressive craniectomy in 116 cases or 
craniectomy+duraplasty without arachnoid 
dissection in 140 cases) was significantly 
worse than the data provided by Kleklamp 
et al (14) in their study (craniectomy, 
opening the arachnoid, opening the 
foramen of Magendie and duraplasty in 371 
cases). In our clinic’s series one of the two 
patients who underwent a simple 
suboccipital craniectomy experienced 
reccurence of symptoms, and needed a 
second surgery for intraarachnoid 
dissection and tonsils coagulation with 
duraplasty. Given the low morbidity rates 
of these studies and the much better long 
term results in the literature for surgery 
techniques that involve at least duraplasty, 
the autor does not support decompression 
without duraplasty (2, 14, 22, 24).  
As for arachnoid opening and dissection 
there is also no unanimous protocol. The 
lower morbidity and complication rates 
reported by some authors are in favor of 
leaving the arachnoid intact (21). In his 
study,  Kleklamp revealed a correlation 
between arachnoid scarring and 
preoperative clinical symptoms and 
neurological outcome, and recommended 
opening the arachnoid in every 
decompression in order to restore CSF 
pathways (27). In light of these studies, the 
author also recommends opening the 
arachnoid and dissection of scarring in 
order reestablish the CSF flow at the level 
of foramen of Magendie.  
Because of high rates of morbidity 
related to syrinx drainage, the author does 
not recommend this maneuver as first 
choice (2, 8, 27). 
 
Conclusions 
Regarding Chiari I malformations, the 
author considers that a proper patient 
selection is critical to prevent unnecessary 
procedures and maximize outcomes. The 
author belives that preoperatory longtime 
neurological deficit is a predictor of poorer 
outcome, making early surgery, mandatory. 
The key point of surgery in Chiari I 
malformation is to allow a CSF flow at the 
level of foramen of Magendie. 
In light of this study results and recent 
literature, the author considers that the 
surgical gold standard consists of three key 
steps:  posterior fossa craniectomy followed 
by durotomy and subarachnoid 
decompression of CSF flow and last, 
duroplasty. 
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